290 related articles for article (PubMed ID: 9705598)
1. Azathioprine in inflammatory bowel disease, a safe alternative?
Tanis AA
Mediators Inflamm; 1998; 7(3):141-4. PubMed ID: 9705598
[TBL] [Abstract][Full Text] [Related]
2. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
[TBL] [Abstract][Full Text] [Related]
3. Adverse effects of azathioprine in the treatment of inflammatory bowel disease.
Martínez F; Nos P; Pastor M; Garrigues V; Ponce J
Rev Esp Enferm Dig; 2001 Dec; 93(12):769-78. PubMed ID: 11995359
[TBL] [Abstract][Full Text] [Related]
4. Toxicity of 6-mercaptopurine/azathioprine in patients with inflammatory bowel disease.
Marion JF
Inflamm Bowel Dis; 1998 May; 4(2):116-7. PubMed ID: 9687219
[No Abstract] [Full Text] [Related]
5. Tolerability and safety of mercaptopurine in azathioprine-intolerant patients with inflammatory bowel disease.
Lees CW; Maan AK; Hansoti B; Satsangi J; Arnott ID
Aliment Pharmacol Ther; 2008 Feb; 27(3):220-7. PubMed ID: 17988235
[TBL] [Abstract][Full Text] [Related]
6. Desensitization of patients with allergic reactions to immunosuppressives in the treatment of inflammatory bowel disease.
Korelitz BI; Reddy B; Bratcher J
Expert Opin Drug Saf; 2010 May; 9(3):379-82. PubMed ID: 20367524
[TBL] [Abstract][Full Text] [Related]
7. [Therapy of chronic inflammatory bowel diseases with azathioprine, 6-mercaptopurine and 6-thioguanine. Clinico-pharmacologic aspects].
Schwab M; Herrlinger K; Schaeffeler E; Stange EF
Dtsch Med Wochenschr; 2003 Feb; 128(8):378-85. PubMed ID: 12594624
[No Abstract] [Full Text] [Related]
8. Increased rates of early adverse reaction to azathioprine in patients with Crohn's disease compared to autoimmune hepatitis: a tertiary referral center experience.
Bajaj JS; Saeian K; Varma RR; Franco J; Knox JF; Podoll J; Emmons J; Levy M; Binion DG
Am J Gastroenterol; 2005 May; 100(5):1121-5. PubMed ID: 15842588
[TBL] [Abstract][Full Text] [Related]
9. Treatment of inflammatory bowel disease with azathioprine and 6-mercaptopurine.
Su C; Lichtenstein GR
Gastroenterol Clin North Am; 2004 Jun; 33(2):209-34, viii. PubMed ID: 15177535
[TBL] [Abstract][Full Text] [Related]
10. Thiopurine drug adverse effects in a population of New Zealand patients with inflammatory bowel disease.
Gearry RB; Barclay ML; Burt MJ; Collett JA; Chapman BA
Pharmacoepidemiol Drug Saf; 2004 Aug; 13(8):563-7. PubMed ID: 15317038
[TBL] [Abstract][Full Text] [Related]
11. Erythema nodosum-like eruption as a manifestation of azathioprine hypersensitivity in patients with inflammatory bowel disease.
de Fonclare AL; Khosrotehrani K; Aractingi S; Duriez P; Cosnes J; Beaugerie L
Arch Dermatol; 2007 Jun; 143(6):744-8. PubMed ID: 17576940
[TBL] [Abstract][Full Text] [Related]
12. Thioguanine: a potential alternate thiopurine for IBD patients allergic to 6-mercaptopurine or azathioprine.
Dubinsky MC; Feldman EJ; Abreu MT; Targan SR; Vasiliauskas EA
Am J Gastroenterol; 2003 May; 98(5):1058-63. PubMed ID: 12809828
[TBL] [Abstract][Full Text] [Related]
13. Thiopurine methyltransferase (TPMT) activity and adverse effects of azathioprine in inflammatory bowel disease: long-term follow-up study of 394 patients.
Gisbert JP; Niño P; Rodrigo L; Cara C; Guijarro LG
Am J Gastroenterol; 2006 Dec; 101(12):2769-76. PubMed ID: 17026564
[TBL] [Abstract][Full Text] [Related]
14. Thiopurine therapy: when to start and when to stop.
McGovern DP; Travis SP
Eur J Gastroenterol Hepatol; 2003 Mar; 15(3):219-23. PubMed ID: 12610314
[TBL] [Abstract][Full Text] [Related]
15. Low-dose azathioprine is effective and safe for maintenance of remission in patients with ulcerative colitis.
Hibi T; Naganuma M; Kitahora T; Kinjyo F; Shimoyama T
J Gastroenterol; 2003; 38(8):740-6. PubMed ID: 14505127
[TBL] [Abstract][Full Text] [Related]
16. Review article: Reproduction in the patient with inflammatory bowel disease.
Heetun ZS; Byrnes C; Neary P; O'Morain C
Aliment Pharmacol Ther; 2007 Aug; 26(4):513-33. PubMed ID: 17661756
[TBL] [Abstract][Full Text] [Related]
17. Adverse events leading to modification of therapy in a large cohort of patients with inflammatory bowel disease.
Hindorf U; Lindqvist M; Hildebrand H; Fagerberg U; Almer S
Aliment Pharmacol Ther; 2006 Jul; 24(2):331-42. PubMed ID: 16842460
[TBL] [Abstract][Full Text] [Related]
18. A triangulation study of the clinician and patient experiences of the use of the immunosuppressant drugs azathioprine and 6-mercaptopurine for the management of inflammatory bowel disease.
Holbrook K
J Clin Nurs; 2007 Aug; 16(8):1427-34. PubMed ID: 17655530
[TBL] [Abstract][Full Text] [Related]
19. Mercaptopurine treatment should be considered in azathioprine intolerant patients with inflammatory bowel disease.
Hindorf U; Johansson M; Eriksson A; Kvifors E; Almer SH
Aliment Pharmacol Ther; 2009 Mar; 29(6):654-61. PubMed ID: 19183142
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic efficacy and safety of 6-mercaptopurine and azathioprine in patients with Crohn's disease.
Markowitz JF
Rev Gastroenterol Disord; 2003; 3 Suppl 1():S23-9. PubMed ID: 12684586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
